login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ITERUM THERAPEUTICS PLC (ITRM) Stock News
USA
-
Nasdaq
- NASDAQ:ITRM -
IE000TTOOBX0
-
Common Stock
0.42
USD
+0.03 (+8.75%)
Last: 11/24/2025, 8:05:21 PM
0.4499
USD
+0.03 (+7.12%)
After Hours:
11/24/2025, 8:05:21 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ITRM Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Chartmill
Iterum Therapeutics PLC (NASDAQ:ITRM) Stock Plummets on Wider-Than-Expected Q3 Loss
6 days ago - By: Benzinga
- Mentions:
ZYXI
ARVN
OLMA
LFMD
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
10 days ago - By: The Motley Fool
Iterum Therapeutics (ITRM) Earnings Transcript
11 days ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Reports Third Quarter 2025 Financial Results
11 days ago - By: Benzinga
- Mentions:
NXXT
DEFT
INKT
CMDB
...
Earnings Scheduled For November 14, 2025
18 days ago - By: Iterum Therapeutics PLC
Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
a month ago - By: Iterum Therapeutics PLC
Iterum Therapeutics to Present Data at IDWeek 2025
2 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Provides Business Update
3 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics launches ORLYNVAHâ„¢, the first and only oral penem antibiotic in the U.S.
4 months ago - By: The Motley Fool
ITRM Reports Results
4 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Reports Second Quarter 2025 Financial Results
4 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025
5 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Iterum Therapeutics PLC
Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAHâ„¢ Launch and Commercial Growth
5 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence
6 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Announces Partnership for Commercialization Services
6 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Announces Extension of Term of Promissory Note
7 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Reports First Quarter 2025 Financial Results
7 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
7 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares
7 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
10 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
10 months ago - By: Iterum Therapeutics PLC
Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025
a year ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Regains Full Nasdaq Compliance
a year ago - By: Iterum Therapeutics PLC
Iterum Therapeutics Reports Third Quarter 2024 Financial Results
Please enable JavaScript to continue using this application.